NPAT quadruples to $429m but underlying profit lifts only 14%

What changed

Revenue rose 50.7% to $4.9b and EBITDAF lifted 15.6% to $905.0m. Reported NPAT jumped 351.6% to $429.0m from $95.0m, but management's underlying NPAT rose only 14% to $359.0m, with the reported figure influenced by net gains on hedge instruments. Operating cash flow climbed 31.0% to $667.0m while capex eased to $281.0m from $316.0m, lifting pre-lease free cash flow to $386.0m from $193.0m. Gross borrowings rose to $1.3b from $1.2b, but leverage on an EBITDAF basis improved to 1.24x from 1.31x. The final dividend of 14.85 cents takes total FY24 ordinary dividends to 21.00 cents per share.

What matters

• Reported-versus-underlying gap. The 372% PBT increase and 352% NPAT increase sit against underlying NPAT growth of 14%. The cleaner operating read is EBITDAF +15.6%; the NPAT line is not a like-for-like signal of earnings power given disclosed hedge-instrument gains.
• Free cash flow step-up funds the dividend. Pre-lease FCF nearly doubled to $386.0m, taking FCF/NPAT (reported) to 90.0% versus 203.2% prior, and covering the ordinary dividend at a 99.4% payout of pre-lease FCF. The prior year's 158.3% FCF payout ratio has materially normalised.
• Leverage direction positive despite higher gross debt. Net debt rose to ~$1.1b from ~$1b, but EBITDAF growth outpaced it, taking net debt/EBITDAF to 1.24x. Equity expanded to $8.2b, partly consistent with asset-base growth (total assets up 35.1%).

Expectations

No quantitative guidance or medium-term target was disclosed in the excerpts. Against HY24 shape context, FY24 was second-half weighted on revenue (HY24 was 43.5% of the full year) but close to evenly split on EBITDAF (HY24 at 49.0%) and NPAT (HY24 at 44.5%). That implies the second-half EBITDAF step-up ($462.0m H2 vs $443.0m H1) was modest, so the FY beat against the prior year is not obviously a run-rate that extrapolates without seasonal and hydrology context the release does not quantify here.

Quality of result

Mixed. The operating result — EBITDAF +15.6% with capex-light FCF of $386.0m and cash conversion improving to 73.7% of EBITDAF from 65.0% — looks durable. However, the headline NPAT is materially assisted by hedge-instrument gains (reported $429.0m versus underlying $359.0m), so the PBT/NPAT line should not be read at face value. Trade receivables rose 60.5% to $536.0m, pushing receivable days from 37.8 to 40.3; the increase broadly tracks the revenue step-up rather than indicating a collection deterioration, but it is a working-capital drag worth monitoring. The effective tax rate lifted to 27.8% from 24.6%, and the PBT-to-NPAT gap is fully explained by tax rather than by a discontinued operation.

Unresolved

• What proportion of the hedge-instrument gain is non-cash versus realised, and how does that shape the durability of reported earnings into FY25?
• What drove the 323-basis-point rise in the effective tax rate, and is 27.8% the new baseline?
• What is the split between retail volumes, wholesale trading and generation in the EBITDAF uplift — segment detail was not in the extracted excerpts?
• Is the 21.0c total ordinary dividend a run-rate intention given FCF cover of 99.4%, or is there headroom assumed from further operating improvement?

This briefing cannot assess hydrology conditions, wholesale price paths, or any capital-programme commitments that would reshape the FCF and leverage trajectory beyond FY24.

Key metrics

Analytical metrics

This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.